LHX vs. ABT
Compare and contrast key facts about L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LHX or ABT.
Correlation
The correlation between LHX and ABT is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LHX vs. ABT - Performance Comparison
Loading data...
Key characteristics
LHX:
0.27
ABT:
1.49
LHX:
0.56
ABT:
2.23
LHX:
1.07
ABT:
1.28
LHX:
0.24
ABT:
1.26
LHX:
0.48
ABT:
7.58
LHX:
12.91%
ABT:
4.25%
LHX:
21.88%
ABT:
21.04%
LHX:
-65.58%
ABT:
-45.66%
LHX:
-11.98%
ABT:
-3.42%
Fundamentals
LHX:
$42.41B
ABT:
$232.01B
LHX:
$8.43
ABT:
$7.99
LHX:
26.91
ABT:
16.69
LHX:
0.34
ABT:
4.17
LHX:
2.00
ABT:
5.48
LHX:
2.22
ABT:
4.75
LHX:
$21.25B
ABT:
$42.34B
LHX:
$5.33B
ABT:
$23.67B
LHX:
$3.74B
ABT:
$11.20B
Returns By Period
In the year-to-date period, LHX achieves a 10.07% return, which is significantly lower than ABT's 20.36% return. Over the past 10 years, LHX has outperformed ABT with an annualized return of 13.49%, while ABT has yielded a comparatively lower 12.80% annualized return.
LHX
10.07%
5.17%
-5.85%
5.78%
7.61%
13.49%
ABT
20.36%
3.93%
17.46%
31.12%
10.41%
12.80%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LHX vs. ABT — Risk-Adjusted Performance Rank
LHX
ABT
LHX vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for L3Harris Technologies, Inc. (LHX) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LHX vs. ABT - Dividend Comparison
LHX's dividend yield for the trailing twelve months is around 2.03%, more than ABT's 1.69% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LHX L3Harris Technologies, Inc. | 2.03% | 2.21% | 2.17% | 2.15% | 1.91% | 1.80% | 1.45% | 1.86% | 1.55% | 2.01% | 2.23% | 2.48% |
ABT Abbott Laboratories | 1.69% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
LHX vs. ABT - Drawdown Comparison
The maximum LHX drawdown since its inception was -65.58%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for LHX and ABT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
LHX vs. ABT - Volatility Comparison
The current volatility for L3Harris Technologies, Inc. (LHX) is 4.76%, while Abbott Laboratories (ABT) has a volatility of 5.61%. This indicates that LHX experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LHX vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between L3Harris Technologies, Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LHX vs. ABT - Profitability Comparison
LHX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, L3Harris Technologies, Inc. reported a gross profit of 1.35B and revenue of 5.13B. Therefore, the gross margin over that period was 26.3%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
LHX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, L3Harris Technologies, Inc. reported an operating income of 525.00M and revenue of 5.13B, resulting in an operating margin of 10.2%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
LHX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, L3Harris Technologies, Inc. reported a net income of 386.00M and revenue of 5.13B, resulting in a net margin of 7.5%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.